Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,247Revenue $M7,374Net Margin (%)-3.4Altman Z-Score1.1
Enterprise Value $M27,273EPS $-0.2Operating Margin %-6.4Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-9.6Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio0.9Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %--Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow36.9y-y EBITDA Growth Rate %-105.1ROA % (ttm)-1.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.9Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M1,341ROIC % (ttm)6.3Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXMario Gabelli 2015-03-31 Reduce-0.02%$13.22 - $18.07
($15.8)
$ 17.3410%Reduce 20.16%1,317,796
BSXDodge & Cox 2015-03-31 Reduce-0.01%$13.22 - $18.07
($15.8)
$ 17.3410%Reduce 38.43%729,460
BSXDodge & Cox 2014-12-31 Reduce-0.49%$11.37 - $13.68
($12.78)
$ 17.3436%Reduce 97.34%1,184,730
BSXVanguard Health Care Fund 2014-12-31 Add0.27%$11.37 - $13.68
($12.78)
$ 17.3436%Add 16.36%59,624,800
BSXLeon Cooperman 2014-09-30 Sold Out -1.1%$11.92 - $13.29
($12.59)
$ 17.3438%Sold Out0
BSXVanguard Health Care Fund 2014-09-30 Add0.25%$11.92 - $13.29
($12.59)
$ 17.3438%Add 19.88%51,242,050
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 17.3433%Reduce 23.25%6,549,479
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 17.3433%Add 16.19%42,743,200
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 17.3447%Reduce 36.64%8,533,099
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 17.3447%Add 17.65%2,000,000
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 17.3447%Reduce 22.34%45,938,468
BSXVanguard Health Care Fund 2013-12-31 Reduce-0.06%$11.18 - $12.38
($11.82)
$ 17.3447%Reduce 3.80%36,787,000
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 17.3447%Sold Out0
BSXMario Gabelli 2013-12-31 Reduce$11.18 - $12.38
($11.82)
$ 17.3447%Reduce 1.50%2,201,305
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 17.3460%Reduce 18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 17.3460%Reduce 27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 17.3460%Reduce 15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 17.3460%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 17.3460%Reduce 69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 17.34104%Reduce 96.31%624,088
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Prange KarenSVP&Pres, Uro & Women's Health 2015-07-07Sell17,456$17.66-1.81view
Nanavaty MaulikSVP & Pres, Neuromodulation 2015-05-29Sell71,558$18.52-6.37view
Carruthers WendySVP, Human Resources 2015-05-28Sell42,281$17.91-3.18view
JOHNSON KRISTINA MDirector 2015-05-18Sell16,301$18.1-4.2view
MARIO ERNESTDirector 2015-05-18Sell50,000$18.09-4.15view
Sununu John EDirector 2015-05-14Sell10,000$17.87-2.97view
Sorenson John BradleySVP, Manuf & Sup Chn 2015-05-11Sell8,735$17.49-0.86view
Ballinger Kevin J.SVP & Pres, Interven Cardio 2015-05-04Sell67,964$17.91-3.18view
Phalen Michael P.EVP & President, MedSurg 2015-03-20Sell46,085$17.94-3.34view
Pierce David ASVP and President, Endoscopy 2015-03-20Sell18,050$18-3.67view

Quarterly/Annual Reports about BSX:

News about BSX:

Articles On GuruFocus.com
Endo Pharmaceuticals Posts A Solid Q1 Earnings Report May 12 2015 
Vanguard Adds to Four of Its Largest Stakes May 04 2015 
Diamond Hill Select Fund Q4 2014 Commentary Mar 17 2015 
Boston Scientific Finally Wins Positive Nod For Watchman Heart Device In U.S. Leaving Investors Impr Mar 17 2015 
Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 
Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 
A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
Boston Scientific Lost the First Place in Innovation Dec 11 2014 
Diamond Hill Capital Comments on Boston Scientific Corp Oct 17 2014 

More From Other Websites
​Four pending product launches at Boston Scientific that investors are watching Jul 31 2015
Abbott Laboratories Earnings Analysis: By the Numbers Jul 29 2015
BOSTON SCIENTIFIC CORP Financials Jul 28 2015
Edited Transcript of BSX earnings conference call or presentation 23-Jul-15 12:00pm GMT Jul 27 2015
Converging On A Heartthrob Market Jul 24 2015
Boston Scientific (BSX) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
Boston Scientific (BSX) Beats Q2 Earnings, Sales View Up - Analyst Blog Jul 23 2015
Boston Scientific beats Street 2Q forecasts Jul 23 2015
Boston Scientific beats Street 2Q forecasts Jul 23 2015
Boston Scientific cuts profit forecast again as legal costs mount Jul 23 2015
Boston Scientific (BSX) Tops Q2 Earnings, Revenue Estimates - Tale of the Tape Jul 23 2015
Boston Scientific Corp Earnings Call scheduled for 8:00 am ET today Jul 23 2015
Boston Scientific Announces Results For Second Quarter 2015 Jul 23 2015
Boston Scientific profit soars Jul 23 2015
BOSTON SCIENTIFIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 23 2015
Q2 2015 Boston Scientific Corp Earnings Release - Before Market Open Jul 23 2015
Boston Scientific Announces Results For Second Quarter 2015 Jul 23 2015
Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire Jul 22 2015
Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire Jul 22 2015
Will Boston Scientific (BSX) Earnings Surprise Investors in Q2? - Analyst Blog Jul 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK